Effect of Breastfeeding Optimization on Early Vascular Development (BRAVO)

This study is currently recruiting participants.
Verified October 2012 by Indonesia University
Sponsor:
Collaborators:
CEEBM
Julius Center
Budi Kemuliaan Hospital
Information provided by (Responsible Party):
Nikmah Salamia Idris, Indonesia University
ClinicalTrials.gov Identifier:
NCT01566812
First received: March 27, 2012
Last updated: October 5, 2012
Last verified: October 2012

March 27, 2012
October 5, 2012
June 2012
December 2013   (final data collection date for primary outcome measure)
  • Cardiovascular risk [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Abdominal aortic/carotid intima media thickness, distensibility, elastic modulus; pulse wave velocity, stiffness index, blood pressure; echocardiography: ejection fraction (%), fractional shortening (%), TAPSE (cm), cardiac index (L/min/m2), LV mass (grams)
  • Breastfeeding habits [ Time Frame: 1 years ] [ Designated as safety issue: No ]
    Breastfeeding practice: Y/N, night/day, frequency (time interval between breastfeeding, e.g 2 hours) Supplementary formula: frequency/day, volume per feeding Complementary feeding: Y/N, type of foods; frequency/day Employer and employee satisfaction
Same as current
Complete list of historical versions of study NCT01566812 on ClinicalTrials.gov Archive Site
  • Child growth [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Body weight, height, head circumference, abdominal circumference
  • Lung function [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Resistance, compliance, time constant, FVC (liters), FEV1 (liters) measured by spirometry
  • Microbiome [ Time Frame: 1 years ] [ Designated as safety issue: No ]
    Infant nasopharyngeal & oral flora, digestive tract/feces flora, maternal oropharyngeal evaluated using PCR and culture.
  • Development [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Bayley Infant Scales, IQ
  • Illness [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Infection/fever, allergic symptoms, wheezing, upper/lower respiratory disease, gastrointestinal symptoms
  • Inflammation [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Serum hs-CRP, Fibrinogen
Same as current
Not Provided
Not Provided
 
Effect of Breastfeeding Optimization on Early Vascular Development
BReast Feeding Attitude and Volume Optimization (BRAVO) Trial: A Randomized Breast Feeding Optimization Experiment

This study aims to find out whether breast feeding optimization will increase breast feeding rates and to evaluate its effect on cardiovascular risk and general health of children.

Breast feeding is suggested to give many benefits for babies and there are some initial prove that it might affect their future health, including the development of cardiovascular diseases. In Indonesia, breast feeding rates are very low, while there is a strong upsurge of cardiovascular disease. In this study, we propose to randomly allocate pregnant Indonesian women who plan to give breast feeding for no more than two months, to either care as usual or to a breast feeding empowerment program lasting to 6 months post partum. At the age of one year, all randomized offspring will undergo non-invasive echographic aortic vascular measurements and cardiovascular risk profiling. Measurements for assessing children's general health status will also be performed, including growth monitoring, repeated lung function test, and microbiomic sampling.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
  • Breast Feeding
  • Cardiovascular Diseases
  • Behavioral: Breast feeding optimization
    Breast feeding optimization program extends from late pregnancy period to 6 months after birth. Prenatal intervention consists of individual and group counseling/education; perinatal intervention consists of in-hospital lactation support; postnatal intervention consists of home visit, counseling session, reminding telephone call and bulk SMS, special counseling for working mothers, breast pump rental, occupational-related support
  • Behavioral: Usual care
    Usual care applied in the hospital
  • Experimental: Breast feeding optimization
    Interventions:
    • Behavioral: Breast feeding optimization
    • Behavioral: Usual care
  • Active Comparator: Usual/routine care
    Intervention: Behavioral: Usual care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1000
December 2017
December 2013   (final data collection date for primary outcome measure)

Inclusion criteria

  • Plan to breast feed for ≤2 months
  • Residing in vicinity ≤ 5 km from the hospital/agree to comply to health visit schedule
  • Telephone communication is possible
  • No known HIV or active tuberculosis in mother
  • Uncomplicated pregnancy
Both
Not Provided
Yes
Contact: Nikmah S Idris, MD 62 81310004373 salamia.nikmah@gmail.com
Contact: Siti Rizny F Saldi, MSc 62 21 3161760 rizny.saldi@gmail.com
Indonesia
 
NCT01566812
BRAVO_trial
No
Nikmah Salamia Idris, Indonesia University
Indonesia University
  • CEEBM
  • Julius Center
  • Budi Kemuliaan Hospital
Principal Investigator: Nikmah S Idris, MD University of Indonesia
Study Chair: Cuno SPM Uiterwaal, Ass Prof, MD, PhD Julius Center
Study Director: Sudigdo Sastroasmoro, Prof, MD, PhD CEEBM, University of Indonesia
Study Director: Rulina Suradi, MD, Prof. University of Indonesia
Study Director: Diederick E Grobbee, Prof, MD, PhD Julius Center
Study Director: Mohammad Baharuddin, MD Budi Kemuliaan Hospital
Study Director: Debby Bogaert, MD, PhD Utrecht University
Principal Investigator: Annemieke MV Evelein, MD Julius Center
Principal Investigator: Wahyuni Indawati, MD University of Indonesia
Indonesia University
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP